$113.350
-0.941 (-0.83%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
ABVX 相似圖表分析預測
Alphio's ABVX stock price prediction model matches the current Abivax SA tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $115.02 (+1.47%). The 1-week path is $115.87 (+2.22%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Abivax SA 股票嗎?
Abivax SA is a good buy right now due to its recent funding of $920 million, which supports the U.S. launch of its drug obefazimod, and the positive analyst ratings with targets up to $180. The current RSI of 27.033 indicates the stock is oversold, suggesting a potential rebound. However, the main risk is the negative forward P/E ratio of 0, indicating uncertainty in future earnings performance.
ABVX 股價於 Friday 收在 $113.35,此前下跌 -0.83%
Abivax SA (ABVX) last closed at $113.35, losing -0.83%. These facts feed the 1-day and 1-week ABVX price prediction above.
預測驅動因素
Abivax SA(ABVX)的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
相似圖表形態
近期走勢與 ABVX 最接近的股票,依相似度排序。
ABVX 季節性分析
Historically the probability of a positive August return for ABVX is 68.25%. September offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。